AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 71 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,646 | -20.9% | 4,985 | 0.0% | 0.00% | – |
| Q2 2023 | $85,492 | -24.8% | 4,985 | -11.6% | 0.00% | – |
| Q1 2023 | $113,739 | +2.6% | 5,639 | +49.1% | 0.00% | – |
| Q4 2022 | $110,813 | +78.7% | 3,782 | +1.6% | 0.00% | – |
| Q3 2022 | $62,000 | -8.8% | 3,722 | -14.3% | 0.00% | – |
| Q2 2022 | $68,000 | -32.0% | 4,342 | -20.3% | 0.00% | – |
| Q1 2022 | $100,000 | +38.9% | 5,446 | -10.8% | 0.00% | – |
| Q4 2021 | $72,000 | -41.0% | 6,106 | +5.4% | 0.00% | – |
| Q3 2021 | $122,000 | – | 5,794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $10,010,000 | 15.59% |
| TCG Crossover Management, LLC | 959,572 | $15,910,000 | 4.77% |
| Atlas Venture Life Science Advisors, LLC | 2,327,909 | $38,597,000 | 4.26% |
| Lynx1 Capital Management LP | 276,447 | $4,583,000 | 4.13% |
| Sofinnova Investments, Inc. | 3,758,686 | $62,319,000 | 3.63% |
| RA Capital Management | 8,263,982 | $137,017,000 | 2.92% |
| Cormorant Asset Management, LP | 2,330,691 | $38,643,000 | 2.70% |
| VR Adviser, LLC | 833,927 | $13,827,000 | 2.13% |
| Ghost Tree Capital, LLC | 150,000 | $2,487,000 | 0.70% |
| Ikarian Capital, LLC | 200,000 | $3,316,000 | 0.66% |